PetriKey

Antimicrobial

Ethambutol

Arabinogalactan synthesis inhibitor

eth-AM-byoo-tol

antimycobacterialarabinosyl-transferasecell-wallembboptic-neuritis

High-yield clue

Ethambutol inhibits arabinosyl transferase (embB) to disrupt arabinogalactan synthesis and is remembered for reversible optic neuritis.

Overview

An antimycobacterial agent studied for inhibiting arabinosyl transferase (encoded by embB) and blocking arabinogalactan incorporation into the mycobacterial cell wall.

Classification

  • Antimycobacterial
  • Inhibits arabinosyl transferase (embB)
  • Blocks arabinogalactan cell-wall assembly
  • Bacteriostatic

Lab & identification clues

  • embB gene resistance mutation concept
  • Cell-wall arabinan synthesis target vocabulary
  • Combination use to limit resistance emergence concept

Associations

  • Tuberculosis regimen study vocabulary
  • Dose-related optic neuritis / red-green color vision concept
  • Visual acuity monitoring study framing

Commonly confused with

  • Isoniazid
  • Pyrazinamide

Your notes

Original mechanism summary for microbiology study. Sources checked: CDC antimicrobial-resistance guidance, NCBI Bookshelf Medical Microbiology, and standard coursework frameworks; reviewed 2026-06. Covers class, mechanism, and resistance vocabulary only; no prescribing, dosing, or patient-specific treatment guidance.

CDC: CDC antimicrobial resistance overview and threat reportssourceWHO: WHO bacterial priority pathogens list 2024sourceNCBI Bookshelf: Medical Microbiology antimicrobial mechanism foundationssource